

SAN FRANCISCO, Oct. 19, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for diagnosing and managing coronary artery disease (CAD), today announced it will release financial results for the third quarter of 2026 after market close on Thursday, November 12, 2026. Management will host a conference call to discuss financial results beginning at 1:30 p.m. PT / 4:30 p.m. ET on November 12, 2026.

Heartflow, Inc. (NASDAQ: HTFL - Get Free Report)'s stock price hit a new 52-week high on Monday. The company traded as high as $52.49 and last traded at $51.8950, with a volume of 819255 shares traded. The stock had previously closed at $49.32. Analysts Set New Price Targets HTFL has been the topic of several recent

Heartflow, Inc. (NASDAQ: HTFL - Get Free Report) CFO Vikram Verghese sold 7,579 shares of the firm's stock in a transaction on Thursday, September 17th. The stock was sold at an average price of $50.11, for a total value of $379,783.69. Following the completion of the transaction, the chief financial officer owned 171,949 shares in the

Heartflow, Inc. (NASDAQ: HTFL - Get Free Report)'s share price reached a new 52-week high during trading on Friday. The company traded as high as $52.22 and last traded at $51.2010, with a volume of 1599729 shares. The stock had previously closed at $49.57. Wall Street Analysts Forecast Growth A number of research analysts recently


Heartflow, Inc. (NASDAQ: HTFL - Get Free Report) CEO John Farquhar sold 35,010 shares of the stock in a transaction on Thursday, September 10th. The stock was sold at an average price of $46.42, for a total value of $1,625,164.20. Following the completion of the transaction, the chief executive officer owned 325,804 shares of the company's

The transaction involved 38,900 shares valued at ~$1.8 million based on a weighted average price of $46.78 per share. The executive traded shares equal to 11% of the equity stake held before the filing.

American Well (NYSE: AMWL - Get Free Report) and Heartflow (NASDAQ: HTFL - Get Free Report) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, profitability, analyst recommendations, earnings, valuation and risk. Valuation and Earnings This table compares American Well and